• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Update: Industry panels disintegrate in wake of Trump remarks

August 16, 2017 By Sarah Faulkner

capitol hillA pair of industry panels convened by President Donald Trump disintegrated today in the wake of his latest comments on the racist violence in Charlottesville.

After Merck (NYSE:MRK) CEO Kenneth Frazier announced on Monday that he planned to leave Trump’s manufacturing advisory panel, a wave of executives followed in his path.

Today, reversing from a statement he made yesterday, Johnson & Johnson (NYSE:JNJ) CEO Alex Gorsky said he also planned to leave the council.

The anger comes in response to the president’s mild-mannered criticism of racist rallies that took place in Charlottesville, Va. this weekend. Yesterday, Trump made remarks in a press conference that appeared to equate white nationalist hate groups with the counter-protesters who were there to oppose them.

Trump tweeted this morning that he planned to disband his manufacturing council and the Strategic and Policy Forum. But his decision reportedly came after members of the president’s councils decided in a phone call that they would all leave the group together, according to the New York Times.

The Strategic and Policy Forum held a phone call this morning to discuss a plan of action and the remaining members of the manufacturing council were slated to have a phone call this afternoon, the news outlet reported.

Trump retaliated against Merck’s CEO after Frazier announced that he planned to leave the manufacturing group on Monday, accusing the company of raising drug prices and sending manufacturing jobs out of the U.S.

“.@Merck Pharma is a leader in higher & higher drug prices while at the same time taking jobs out of the U.S. Bring jobs back & LOWER PRICES!,” Trump tweeted.

The percentage of U.S.-based employees at Merck has stayed steady since Frazier became CEO in 2011 – around 38%, according to CNBC.

Trump has repeatedly criticized the pharmaceutical industry about its drug pricing practices and it has previously sent pharma stock prices down. But Trump’s attacks directed at Merck did not seem to deter investors and Merck shares were trading up 8% in morning activity on Monday.

Former Medtronic (NYSE:MDT) chairman & CEO, Bill George, penned an article for CNBC regarding the responsibility that executives have to stand up for their company’s values.

“As the public dialogue becomes more divisive, I anticipate that more business leaders will be taking public stands on behalf of the people and organizations they represent,” George wrote. “I admire their courage and willingness to do so. Even when we disagree with them, we should be respectful of their bravery to stand up and be counted when the issues matter the most.”

See the best minds in medtech live at DeviceTalks Boston on Oct. 2. 

Filed Under: Featured, Pharmaceuticals, Policy, Wall Street Beat Tagged With: Capitol Hill, johnsonandjohnson, Medtronic, Merck

IN CASE YOU MISSED IT

  • Medtronic Diabetes names CFO with consumer experience ahead of separation
  • Diabeloop launches insulin delivery algorithm in Germany
  • GlucoModicum has positive data for needle-free CGM
  • Lifecare takes next steps in CGM implant development
  • Ypsomed brings autoinjector for dual GCG/GLP-1 delivery to China

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS